Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20709593 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders
Condition: Hepatitis C
Intervention: Drug: Silibinin

Study has passed its completion date and status has not been verified in more than two years.